The Great Manipulator, page-25

Haha, if it's the age report you're referring too then nothing much new, in fact, read though it, for CSL it's a positive, here's a couple:

"One industry expert said CSL would be in the box seat if the sector faced tighter regulation, because its governance practices were already best in class."

"Unlike other players in the US market, CSL has more consistent internal systems for collection and donor monitoring and would be ready to move faster than competitors to roll out new requirements"

"CSL chief medical officer Dr Charmaine Gittleson said there were no ethical or health concerns associated with blood plasma donation, saying it was in CSL's best interests to ensure the ongoing health of donors and there were no large long-term studies linking health risks to frequent donations. "We have 48 million donations happening each year and every plasma centre is monitoring them for safety. All of that information gets collected and put into formal systems. Regulators are able to look at data across the years and are able to track the safety of donations," she said. And we have not seen any significant regulatory changes to how [plasma] is collected."

https://www.theage.com.au/business/companies/csl-s-blood-payments-in-us-under-the-microscope-20200423-p54mnu.html